In Global News: Early Menopause From Chemotherapy, Cardiovascular Disease Risk App, and New ESC/EACTS Guidelines

Patient Care and General Interest

Late-breaking results from the VISION study just presented at the European Society of Cardiology’s 2018 annual Congress suggest that 75% of patient deaths after noncardiac surgery can be attributed to cardiovascular causes.

Access to the Affordable Care Act in the United States has seemingly made middle-aged stroke survivors less likely to skip prescribed medications due to cost.

A new study suggests that chemotherapy may lead to early menopause in young women with lung cancer.

Drugs and Devices

A new Astrazeneca drug called Tagrisso has been approved in Japan for patients with inoperable or recurrent epidermal growth factor receptor mutation-positive non-small-cell lung cancer.

The Duke Clinical Research Institute and Cerner have jointly developed an app that estimates patients’ cardiovascular disease risk.

Research, Trials, and Funding

A new study published in the Journal of the American Heart Association finds that a simplified cardiac magnetic resonance protocol can help developing nations diagnose heart ailments more quickly and cheaply.

A meta-analysis published in JAMA Cardiology finds that young and middle-aged adults with aortic valve disease have a higher survival rate when treated via the Ross procedure as opposed to mechanical aortic valve replacement.

New guidelines on clinical care for patients undergoing myocardial revascularization have been released by the European Society of Cardiology and European Association for Cardio-Thoracic Surgery.